Cargando…
Efficacy and safety of fluticasone propionate/formoterol fumarate in pediatric asthma patients: a randomized controlled trial
BACKGROUND: The efficacy and safety of fluticasone propionate/formoterol fumarate pressurized metered-dose inhaler (pMDI) (fluticasone/formoterol; Flutiform(®); 100/10 µg b.i.d.) was compared with fluticasone propionate (Flixotide(®) Evohaler(®) pMDI; 100 µg b.i.d.) and fluticasone/salmeterol (Seret...
Autores principales: | Płoszczuk, Anna, Bosheva, Miroslava, Spooner, Kay, McIver, Tammy, Dissanayake, Sanjeeva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985608/ https://www.ncbi.nlm.nih.gov/pubmed/29857783 http://dx.doi.org/10.1177/1753466618777924 |
Ejemplares similares
-
Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations
por: Papi, Alberto, et al.
Publicado: (2016) -
The EFFECT trial: evaluating exacerbations, biomarkers, and safety outcomes with two dose levels of fluticasone propionate/formoterol in COPD
por: Papi, Alberto, et al.
Publicado: (2015) -
Non-interventional study of the safety and effectiveness of
fluticasone propionate/formoterol fumarate in real-world asthma
management
por: Backer, Vibeke, et al.
Publicado: (2018) -
The efficacy and safety of fluticasone propionate/formoterol compared
with fluticasone propionate/salmeterol in treating pediatric asthma: a
systematic review and meta-analysis
por: Guan, Renzheng, et al.
Publicado: (2019) -
The comparison of fluticasone propionate/formoterol with fluticasone propionate/salmeterol for paediatric asthma: a meta-analysis of randomized controlled trials
por: Jin, Xiaofen, et al.
Publicado: (2020)